Ocular implant containing an active ingredient
AssigneeOcular Therapeutix, Inc.
InventorsCharles D. BLIZZARD, Arthur DRISCOLL, Rami EL-HAYEK, Michael GOLDSTEIN, Joseph IACONA, Peter JARRETT, Timothy S. JARRETT, Erica KAHN, Zachary LATTRELL
Life of this patent
Estimating the term…
Abstract
The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
Claims6
A sustained release biodegradable ocular implant comprising a hydrogel and an active agent, wherein active agent particles are dispersed within the hydrogel, and wherein the implant in its dry state has a length of less than about 17 mm, wherein the active agent is not a tyrosine kinsase inhibitor.
2-111. (canceled)
113-158. (canceled)
160-209. (canceled)
Dependencies are inferred from the claim text.